- Home
- DECK vs BNTX Comparison
DECK vs BNTX Comparison
Compare DECK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DECK
- BNTX
- Stock Information
- Founded
- DECK 1973
- BNTX 2008
- Country
- DECK United States
- BNTX Germany
- Employees
- DECK N/A
- BNTX N/A
- Industry
- DECK Shoe Manufacturing
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DECK Consumer Discretionary
- BNTX Health Care
- Exchange
- DECK Nasdaq
- BNTX Nasdaq
- Market Cap
- DECK 15.2B
- BNTX 26.4B
- IPO Year
- DECK 1993
- BNTX 2019
- Fundamental
- Price
- DECK $101.80
- BNTX $112.71
- Analyst Decision
- DECK Buy
- BNTX Strong Buy
- Analyst Count
- DECK 22
- BNTX 18
- Target Price
- DECK $144.56
- BNTX $141.60
- AVG Volume (30 Days)
- DECK 2.8M
- BNTX 722.4K
- Earning Date
- DECK 07-24-2025
- BNTX 08-04-2025
- Dividend Yield
- DECK N/A
- BNTX N/A
- EPS Growth
- DECK 30.25
- BNTX N/A
- EPS
- DECK 6.33
- BNTX N/A
- Revenue
- DECK $4,985,612,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- DECK $10.38
- BNTX N/A
- Revenue Next Year
- DECK $7.85
- BNTX $10.68
- P/E Ratio
- DECK $16.07
- BNTX N/A
- Revenue Growth
- DECK 16.27
- BNTX 0.61
- 52 Week Low
- DECK $93.72
- BNTX $76.53
- 52 Week High
- DECK $223.98
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- DECK 40.61
- BNTX 63.00
- Support Level
- DECK $104.05
- BNTX $105.35
- Resistance Level
- DECK $106.86
- BNTX $114.00
- Average True Range (ATR)
- DECK 2.84
- BNTX 2.62
- MACD
- DECK 0.45
- BNTX 0.53
- Stochastic Oscillator
- DECK 38.06
- BNTX 89.37
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and about 180 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.